Skip to main content
. Author manuscript; available in PMC: 2011 Jul 19.
Published in final edited form as: Vaccine. 2010 Jun 10;28(32):5245–5253. doi: 10.1016/j.vaccine.2010.05.062

TABLE 4.

Incremental Cost-Effectiveness Ratio ($US/DALY prevented) of Vaccination for Initial Prevention of Clostridium difficile infection (CDI) using the Opportunity Cost of Lost Bed-Days Approach.

Vaccine
Efficacy
Clostridium difficile Risk
0.1% 1.0% 2.5% 5.0% 10.0% 15.0% 20.0% 25.0%
Cost of Vaccination = $25
25% 102,512,396 5,802,049 3,150,365 670,243 219,928 159,819 51,886 9,750
50% 7,835,447 1,774,240 1,120,416 235,026 46,099 Dominant Dominant Dominant
75% 9,242,325 1,135,269 437,496 125,266 Dominant Dominant Dominant Dominant
100% 13,588,967 1,114,979 300,389 56,679 Dominant Dominant Dominant Dominant
Cost of Vaccination = $50
25% 355,495,778 9,495,689 4,775,304 1,901,144 697,507 419,099 312,448 189,174
50% 62,561,269 3,928,690 2,619,269 674,142 260,932 130,529 54,358 5,540
75% 38,053,933 3,606,097 1,274,169 448,297 134,118 29,308 Dominant Dominant
100% 31,053,420 2,377,616 755,625 271,070 46,872 Dominant Dominant Dominant
Cost of Vaccination = $100
25% 397,800,954 14,296,136 13,956,184 2,151,773 1,241,526 1,089,628 878,411 949,495
50% 121,217,228 7,336,363 2,797,316 1,645,005 885,973 436,334 277,371 196,372
75% 99,166,559 6,559,099 2,093,538 994,250 421,389 227,919 143,188 68,418
100% 34,978,919 6,098,157 1,590,522 695,307 285,349 147,266 54,144 10,528

NOTE: Dominant = Vaccination is the dominant strategy (i.e., less costly and more effective)